Discovery and in vitro evaluation of potent kinase inhibitors:: Pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines

被引：31

作者：

Alberti, MJ ^{[1
]}

Auten, EP ^{[1
]}

Lackey, KE ^{[1
]}

McDonald, OB ^{[1
]}

Wood, ER ^{[1
]}

Preugschat, F ^{[1
]}

Cutler, GJ ^{[1
]}

Kane-Carson, L ^{[1
]}

Liu, W ^{[1
]}

Jung, DK ^{[1
]}

机构：

[1] GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 16期

关键词：

kinase inhibitor; VEGFR; GSK; Erb; EGFR;

D O I：

10.1016/j.bmcl.2005.05.100

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The discovery, synthesis, potential binding mode, and in vitro kinase profile of several pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines as potent kinase inhibitors are discussed. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：3778 / 3781

页数：4

共 50 条

[31] SYNTHESIS OF NEW PYRIDO[2′,3′:3,4] PYRAZOLO[1,5-a] PYRIMIDINES AND THEIR USE IN THE PREPARATION OF TETRAHETEROCYCLIC SYSTEMS
El-Essawy, Farag A.
SYNTHETIC COMMUNICATIONS, 2010, 40 (06) : 877 - 887
[32] PREPARATION OF SOME 1- AND 2-BETA-D-RIBOFURANOSYL-PYRAZOLO[3,4-D]PYRIMIDINES
DAVOLL, J
KERIDGE, KA
JOURNAL OF THE CHEMICAL SOCIETY, 1961, (JUN): : 2589 - &
[33] Regioselectivity of 1,3-dipolar cycloadditions and antimicrobial activity of isoxazoline, pyrrolo[3,4-d]isoxazole-4,6-diones, pyrazolo[3,4-d]pyridazines and pyrazolo[1,5-a]pyrimidines
Zaki, Yasser Hassan
Sayed, Abdelwahed Rashad
Elroby, Shaaban A.
CHEMISTRY CENTRAL JOURNAL, 2016, 10
[34] Regioselectivity of 1,3-dipolar cycloadditions and antimicrobial activity of isoxazoline, pyrrolo[3,4-d]isoxazole-4,6-diones, pyrazolo[3,4-d]pyridazines and pyrazolo[1,5-a]pyrimidines
Yasser Hassan Zaki
Abdelwahed Rashad Sayed
Shaaban A. Elroby
Chemistry Central Journal, 10
[35] REACTIONS OF URACILS .3. PYRAZOLO[3,4-D]PYRIMIDINES AND PYRIDO[2,3-D]PYRIMIDINES FROM 5-FORMYL-1,3-DIMETHYLURACILS
MATYUS, P
SOHAR, P
WAMHOFF, H
HETEROCYCLES, 1984, 22 (03) : 513 - 518
[36] Synthesis and biological evaluation of a series of substituted pyrazolo [3,4-d]-1,2,3-triazoles and pyrazolo[3,4-d]oxazoles
Vicentini, CB
Manfredini, S
Manfrini, M
Bazzanini, R
Musiu, C
Putzolu, M
Perra, G
Marongiu, ME
ARCHIV DER PHARMAZIE, 1998, 331 (09) : 269 - 272
[37] In silico screening of a series of 1,6-disubstituted 1H-pyrazolo[3,4-d]pyrimidines as potential selective inhibitors of the Janus kinase 3
Faris, Abdelmoujoud
Hadni, Hanine
Saleh, Basil A.
Khelfaoui, Hadjer
Harkati, Dalal
Ait Ahsaine, Hassan
Elhallaoui, Menana
El-Hiti, Gamal A.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, : 4456 - 4474
[38] Synthesis, anticancer evaluation, molecular docking and ADME study of novel pyrido[4ʹ,3ʹ:3,4]pyrazolo[1,5-a]pyrimidines as potential tropomyosin receptor kinase A (TrKA) inhibitors
Nadia Hanafy Metwally
Emad Abdullah Deeb
Ibrahim Walid Hasani
BMC Chemistry, 18
[39] Synthesis, anticancer evaluation, molecular docking and ADME study of novel pyrido[4′,3′:3,4]pyrazolo[1,5-a]pyrimidines as potential tropomyosin receptor kinase A (TrKA) inhibitors
Metwally, Nadia Hanafy
Deeb, Emad Abdullah
Hasani, Ibrahim Walid
BMC CHEMISTRY, 2024, 18 (01)
[40] Design, synthesis and brief SAR of pyrazolo[3,4-d] and pyrrolo[2,3-d]pyrimidines as potent inhibitors of LCK.
Burchat, AF
Calderwood, DJ
Deng, BJ
Friedman, M
Hirst, G
Li, BQ
Ritter, K
Skinner, B
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U25 - U25

← 1 2 3 4 5 →